Account-Based Marketing for Healthcare: Where to Focus First

Account-based marketing for healthcare companies works best when it treats complex buying groups as the unit of focus, not individual contacts. In healthcare, a single purchasing decision can involve clinicians, procurement, compliance, finance, and executive leadership, sometimes across multiple sites. ABM is structurally suited to that complexity in a way that broad demand generation simply is not.

The strategies that perform in this space are not exotic. They are disciplined applications of account selection, message relevance, and coordinated outreach, executed with more patience than most marketing teams are used to committing to.

Why Standard Demand Generation Breaks Down in Healthcare

I spent time running agency teams across a range of B2B verticals, and healthcare was consistently the one where clients arrived with the most mismatched expectations. They had built their marketing model on lead volume, MQL targets, and nurture sequences designed for sales cycles measured in days. Then they wondered why pipeline was thin and sales were frustrated.

Healthcare procurement does not work that way. A hospital system evaluating a new diagnostics platform is not going to convert from a whitepaper download and three follow-up emails. The decision involves clinical stakeholders who care about outcomes data, procurement teams who care about contract terms, IT who care about integration, and compliance who care about regulatory exposure. Getting one of them interested is not the same as moving a deal forward.

Forrester has written directly about these go-to-market challenges facing healthcare device and diagnostics companies, and the pattern is consistent: organisations built for transactional selling struggle when the buying process is inherently committee-based. ABM is the structural answer to that problem, but only when it is implemented with the discipline the model actually requires.

If you are working through broader growth strategy questions alongside your ABM programme, the Go-To-Market and Growth Strategy hub covers the commercial frameworks that sit underneath channel-level decisions like this one.

How to Select the Right Accounts Without Wasting the Model

Account selection is where healthcare ABM programmes either earn their investment or squander it. I have seen this go wrong in both directions. Some teams select so few accounts that the programme cannot generate meaningful pipeline. Others select so many that the personalisation and coordination that define ABM disappear entirely, and what remains is just segmented email marketing with a different name.

The starting point is an honest ideal customer profile built from closed-won data, not aspiration. Which accounts have actually converted, retained, and expanded? What did they have in common structurally, not just demographically? In healthcare, that often means looking at factors like organisation size, payer mix, existing technology infrastructure, geographic market, and whether the account has a history of adopting new clinical or operational technologies.

From there, tiering matters. A one-tier ABM model, where every account gets the same level of personalisation and resource, is rarely sustainable. Most healthcare ABM programmes that work use a three-tier structure. Tier one accounts, typically 10 to 30 for a mid-market company, get bespoke content, executive engagement, and direct sales coordination. Tier two accounts get industry-relevant content and targeted outreach. Tier three accounts get a more programmatic approach, closer to traditional demand generation but with account-level targeting.

The mistake I see repeatedly is over-investing in account selection criteria that are easy to measure, like company size and geography, and under-investing in intent signals and relationship mapping. If you know which accounts are already researching solutions in your category, that intelligence should shape your tier assignments more than a firmographic filter.

Mapping the Healthcare Buying Committee Properly

In healthcare, the buying committee is not a metaphor. It is a literal group of people with different priorities, different vocabularies, and different definitions of success, all of whom have some form of influence over the outcome. Marketing to one of them while ignoring the others is a structural mistake that no amount of creative quality will fix.

The committee composition varies by solution type, but a typical enterprise healthcare technology purchase might include a Chief Medical Officer or clinical champion, a Chief Information Officer or IT director, a VP of Operations, a procurement lead, a compliance or legal representative, and a finance stakeholder. Each of them is evaluating your solution through a different lens.

The clinical champion cares about patient outcomes and workflow integration. The CIO cares about security, interoperability, and implementation complexity. Finance cares about total cost of ownership and ROI timelines. Compliance cares about regulatory risk. Procurement cares about contract terms and vendor stability. Marketing content that speaks to one of these audiences while being irrelevant or off-putting to the others is not just inefficient, it can actively damage the relationship with the stakeholders it ignores.

Effective healthcare ABM requires content and messaging mapped to each stakeholder role, delivered through the channels each role actually uses. That is more work than most marketing teams plan for when they start an ABM programme, which is one reason why account selection discipline matters so much. You cannot do this properly for 500 accounts. You can do it properly for 30.

What Content Actually Works in Healthcare ABM

Healthcare is a credibility-first environment. The clinical and operational stakeholders who influence purchasing decisions have seen enough vendor marketing to be sceptical of anything that reads like a sales document in disguise. Content that lacks genuine clinical or operational substance gets filtered out quickly, often before it reaches the people who matter most.

The content formats that tend to perform in healthcare ABM share a few characteristics. They are specific rather than generic. They use real outcomes data from comparable organisations rather than abstract claims. They acknowledge the complexity of implementation rather than glossing over it. And they are written with enough domain knowledge that a clinical or operational reader can tell the author understands their world.

Case studies are the workhorse format in this space, but they need to be genuinely detailed to do their job. A two-paragraph case study with a headline metric is not convincing to a procurement team evaluating a seven-figure contract. A detailed account of how a comparable health system implemented the solution, what the challenges were, how they were resolved, and what the measurable outcomes were over 12 months, that is a different proposition entirely.

Executive briefings work well for tier-one accounts when they are built around the specific account’s context rather than generic industry content. If you know a target health system is in the middle of a merger integration, a briefing that addresses the specific operational challenges that creates is far more relevant than a standard capabilities overview. That level of specificity requires account intelligence, which is why research and insight should sit upstream of content production in any serious healthcare ABM programme.

Webinars and peer roundtables can be effective for warming tier-two accounts, particularly when they feature clinical or operational voices from outside your organisation. A webinar hosted by a vendor is a sales event. A roundtable featuring three clinical leaders from health systems discussing a shared operational challenge is a different kind of conversation, and healthcare buyers respond to it differently.

Channel Strategy for Healthcare ABM: Where to Actually Reach These Buyers

One of the persistent myths in healthcare B2B marketing is that LinkedIn is the only digital channel worth using for professional audiences. LinkedIn matters, but treating it as the whole answer leads to programmes that are both expensive and incomplete.

LinkedIn’s account-based targeting is genuinely useful for healthcare ABM, particularly for reaching administrative and operational titles. But clinical audiences, especially physicians and nursing leadership, are harder to reach through LinkedIn and often more accessible through medical publications, professional association channels, and clinical conference environments. A healthcare ABM programme that ignores those channels is optimising for the stakeholders who are easiest to reach digitally, not necessarily the ones whose buy-in is most important.

Direct mail has seen a quiet rehabilitation in healthcare B2B, partly because the inbox is so saturated and partly because physical materials signal a level of investment that digital outreach does not. For tier-one accounts, a well-produced physical briefing document sent to a named executive can stand out in a way that a personalised email simply cannot. I am not suggesting a return to mass direct mail campaigns. I am suggesting that for 20 or 30 carefully selected accounts, a physical touchpoint can be a meaningful part of the engagement sequence.

Events remain important in healthcare, both industry conferences and account-specific events. The annual healthcare technology conferences are genuine relationship-building environments, not just lead-generation theatre. If your tier-one accounts have executives attending a specific conference, your presence and your agenda at that conference should be coordinated with your ABM programme, not treated as a separate activity managed by a different team.

Paid digital channels, including programmatic display and search, can support healthcare ABM when they are configured for account-level targeting rather than broad audience reach. The distinction matters. Broad awareness campaigns in healthcare generate impressions without generating the right impressions. Account-level targeting, where your digital spend is concentrated on IP addresses and matched audiences associated with your target accounts, is a different and more defensible use of budget.

Sales and Marketing Alignment in Healthcare ABM: The Part That Actually Determines Success

I will be direct about this because I have watched too many ABM programmes underperform for a reason that had nothing to do with strategy or content quality. The programmes that fail most consistently in healthcare are the ones where sales and marketing are running parallel tracks rather than a coordinated programme.

Healthcare sales cycles are long. A complex enterprise deal can take 12 to 24 months from first meaningful engagement to contract signature. During that period, the account will be touched by marketing content, by sales outreach, by customer success if there is an existing relationship, and potentially by executive sponsors. If those touchpoints are not coordinated, they create friction rather than momentum. A clinical stakeholder who receives a generic awareness email from marketing the same week they are in a detailed technical conversation with a sales engineer is getting a signal that the vendor does not have its act together.

The structural fix is straightforward but requires genuine commitment from both functions. Account plans for tier-one accounts should be jointly owned by marketing and sales. Marketing should know what stage each account is at in the sales process and calibrate content and outreach accordingly. Sales should know what marketing touchpoints each stakeholder in the account has received and use that intelligence in their conversations.

BCG’s research on go-to-market alignment between marketing and commercial functions makes the case that the coordination dividend is real and measurable. In healthcare ABM specifically, where the buying cycle is long and the stakeholder map is complex, that coordination is not a nice-to-have. It is the difference between a programme that generates pipeline and one that generates activity reports.

Measuring Healthcare ABM Without Fooling Yourself

Measurement in ABM is genuinely harder than measurement in demand generation, and healthcare makes it harder still. The buying cycle is long, the committee is large, and attribution across multiple touchpoints over 18 months is more art than science. Anyone who tells you otherwise is probably selling you a measurement platform.

The metrics that matter most in healthcare ABM are engagement metrics at the account level, not the contact level. Are the right people within target accounts engaging with your content? Are you reaching new stakeholders within accounts over time, or just repeatedly reaching the same one? Is account engagement increasing as you move through the programme? These signals are more meaningful than MQL counts or email open rates, which measure activity rather than progress.

Pipeline metrics matter, but they need context. A healthcare ABM programme running for six months should not be expected to show closed revenue. It should show account engagement, stakeholder coverage, and movement through the buying stages for tier-one accounts. If none of your tier-one accounts have progressed in any measurable way after six months, that is a signal worth investigating. But expecting revenue attribution from a programme that has been running for two quarters in a 24-month sales cycle is a category error.

Qualitative signals matter more in healthcare ABM than in most other contexts. Sales feedback on the quality of conversations, account-level feedback gathered through customer success relationships, and the intelligence that comes from being closer to specific accounts over time are all forms of measurement that do not show up in a dashboard but are genuinely informative about programme effectiveness.

I spent years managing large performance marketing budgets across multiple industries, and the discipline I learned from that experience was to be honest about what the numbers were actually telling me versus what I wanted them to tell me. In healthcare ABM, the temptation is to measure what is easy rather than what is meaningful. Resisting that temptation requires the same kind of intellectual honesty.

The broader frameworks for thinking about growth measurement and go-to-market effectiveness are covered in more depth across the Go-To-Market and Growth Strategy section of this site, if you want to think through the commercial logic that sits underneath channel-level measurement decisions.

The Organisational Realities That Determine Whether Healthcare ABM Actually Works

Healthcare ABM is not a campaign. It is a programme, and the distinction matters for how you resource and manage it. Campaigns have defined start and end dates. They are planned, executed, and evaluated in discrete cycles. ABM in healthcare is a sustained engagement model that runs in parallel with sales activity over periods measured in years, not quarters.

That has real implications for resourcing. A healthcare ABM programme that is treated as a campaign and handed to a team that is also managing product launches, event logistics, and content calendars will underperform. The accounts will not receive the sustained attention the model requires, and the coordination with sales will deteriorate as other priorities compete for attention.

The organisations that do this well tend to have dedicated ABM resources, even if small, rather than distributing the work across a generalist team. They have clear account ownership, both on the marketing side and the sales side. And they have executive sponsorship that protects the programme from being cannibalised by short-term demand generation targets when pipeline pressure increases.

BCG’s work on scaling agile commercial models is relevant here, not because ABM is an agile methodology, but because the organisational principles around dedicated teams, clear ownership, and iterative improvement apply directly to how a healthcare ABM programme should be structured and managed over time.

One thing I would add from experience: the healthcare companies that get the most from ABM are the ones that treat account intelligence as an ongoing investment rather than a one-time exercise. The accounts on your target list are not static. Leadership changes, strategic priorities shift, budget cycles move. A programme that refreshes its account intelligence regularly, and adjusts its engagement accordingly, will consistently outperform one that sets its account plans at the start of the year and revisits them at the end.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions